Literature DB >> 11778899

Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways.

S P Goff1.   

Abstract

Retroviruses enter cells through specific cell-surface receptors and then embark on a journey that ultimately leads to the establishment of the integrated proviral DNA. The steps of the journey include the reverse transcription of the viral RNA into DNA, the trafficking of the viral protein-DNA complex through the cytoplasm, the entry of the complex into the nucleus, and the insertion of the linear viral DNA into the host genome. All these steps are likely to involve specific interactions of viral proteins with host machinery. Our knowledge of the details of these interactions is very limited but is rapidly expanding, and should provide a deeper understanding of the pathways and components used by the different classes of retroviruses. This knowledge in turn should enable the development of better and more efficient retroviral vectors for use in gene therapy protocols in vivo.

Mesh:

Substances:

Year:  2001        PMID: 11778899     DOI: 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  49 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  Recent advances in the study of active endogenous retrovirus envelope glycoproteins in the mammalian placenta.

Authors:  Yufei Zhang; Jing Shi; Shuying Liu
Journal:  Virol Sin       Date:  2015-08-18       Impact factor: 4.327

3.  Detection and Tracking of Dual-Labeled HIV Particles Using Wide-Field Live Cell Imaging to Follow Viral Core Integrity.

Authors:  João I Mamede; Thomas J Hope
Journal:  Methods Mol Biol       Date:  2016

4.  Seeing is believing: structure of the catalytic domain of HIV-1 integrase in complex with human LEDGF/p75.

Authors:  Christina Marchetti Bradley; Robert Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-28       Impact factor: 11.205

5.  High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 6.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

7.  Identification of a novel human immunodeficiency virus type 1 integrase interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo.

Authors:  Seiji Hamamoto; Hironori Nishitsuji; Teruo Amagasa; Mari Kannagi; Takao Masuda
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae.

Authors:  Michael Aye; Becky Irwin; Nadejda Beliakova-Bethell; Eric Chen; Jennifer Garrus; Suzanne Sandmeyer
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

9.  Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus -1 preintegration complex (DNA).

Authors:  Ruonan Zhang; Rajeev Mehla; Ashok Chauhan
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

10.  Augmentation of reverse transcription by integrase through an interaction with host factor, SIP1/Gemin2 Is critical for HIV-1 infection.

Authors:  Hironori Nishitsuji; Takaya Hayashi; Takuya Takahashi; Masashi Miyano; Mari Kannagi; Takao Masuda
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.